Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Rush Enterprises Class A
RUSHA
$8.54B
| $104M | 0.05% |
2,556,734
+500,331
| +24% | +$18.4M |
|
352
CSX Corp
CSX
$95.6B
| $103M | 0.05% |
3,021,376
-2,779,872
| -48% | -$87.9M |
|
353
Medpace
MEDP
$17.3B
| $103M | 0.05% |
428,777
+21,234
| +5% | +$4.41M |
|
354
AT&T
T
$173B
| $103M | 0.05% |
6,441,792
-12,993,565
| -67% | -$221M |
|
355
Warner Bros
WBD
$71.6B
| $102M | 0.05% |
8,153,779
+1,736,632
| +27% | +$22.5M |
|
356
PUT
lululemon athletica
LULU
$13.7B
| $102M | 0.05% |
269,300
+246,500
| +1,081% | +$90.9M |
|
357
Coca-Cola Europacific Partners
CCEP
$47.7B
| $102M | 0.05% |
1,578,614
-574,498
| -27% | -$36.5M |
|
|
PPL
358
PPL Corp
PPL
$25.9B
| $102M | 0.05% |
3,842,138
+127,449
| +3% | +$3.51M |
|
359
CALL
Eli Lilly
LLY
$1.12T
| $101M | 0.05% |
216,300
+87,800
| +68% | +$36.8M |
|
360
Fair Isaac
FICO
$25.3B
| $101M | 0.05% |
124,818
+118,450
| +1,860% | +$88.8M |
|
361
CALL
Morgan Stanley
MS
$336B
| $101M | 0.05% |
1,177,500
-62,100
| -5% | -$5.31M |
|
362
Avantor
AVTR
$9.78B
| $100M | 0.05% |
4,873,199
+3,445,637
| +241% | +$69.7M |
|
363
Elevance Health
ELV
$86.9B
| $100M | 0.05% |
225,219
-96,712
| -30% | -$44.6M |
|
364
Healthpeak Properties
DOC
$14.8B
| $99.5M | 0.05% |
4,951,614
+3,217,789
| +186% | +$66.8M |
|
365
CALL
T-Mobile US
TMUS
$196B
| $98.9M | 0.05% |
712,100
+432,900
| +155% | +$60.8M |
|
366
XPO
XPO
$23.2B
| $98.5M | 0.05% |
1,670,023
+567,328
| +51% | +$25.7M |
|
|
367
CALL
Home Depot
HD
$335B
| $98.3M | 0.05% |
316,300
-8,600
| -3% | -$2.54M |
|
|
NVO
368
Novo Nordisk
NVO
$207B
| $98.2M | 0.05% |
1,213,674
+190,546
| +19% | +$15.6M |
|
|
ATVI
369
CALL
DELISTED
Activision Blizzard
ATVI
| $98.2M | 0.05% |
1,164,600
+498,900
| +75% | +$40.4M |
|
370
CALL
Boeing
BA
$169B
| $98M | 0.05% |
464,300
-291,400
| -39% | -$60.5M |
|
371
Teledyne Technologies
TDY
$29.5B
| $98M | 0.05% |
238,423
+114,490
| +92% | +$47.2M |
|
372
AutoZone
AZO
$48.3B
| $97.9M | 0.05% |
39,260
+19,899
| +103% | +$50.7M |
|
373
PUT
Merck
MRK
$376B
| $97.6M | 0.05% |
845,600
+488,200
| +137% | +$55.4M |
|
374
Bio-Rad Laboratories Class A
BIO
$10.2B
| $97.3M | 0.05% |
256,564
-200,716
| -44% | -$81.7M |
|
|
SF
375
Stifel
SF
$12.2B
| $96.9M | 0.05% |
2,436,519
-458,097
| -16% | -$17.9M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.